PAIELLA, Salvatore
 Distribuzione geografica
Continente #
EU - Europa 10.177
NA - Nord America 9.211
AS - Asia 6.412
SA - Sud America 1.006
AF - Africa 181
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 4
Totale 27.012
Nazione #
US - Stati Uniti d'America 8.996
RU - Federazione Russa 4.643
SG - Singapore 2.690
CN - Cina 1.919
GB - Regno Unito 1.338
IT - Italia 1.180
BR - Brasile 839
HK - Hong Kong 700
DE - Germania 669
SE - Svezia 534
IE - Irlanda 494
FR - Francia 470
VN - Vietnam 399
FI - Finlandia 263
NL - Olanda 171
KR - Corea 164
CA - Canada 113
IN - India 98
JP - Giappone 97
MX - Messico 76
UA - Ucraina 75
AR - Argentina 68
PL - Polonia 56
AT - Austria 55
TR - Turchia 53
ES - Italia 49
ID - Indonesia 47
BD - Bangladesh 43
ZA - Sudafrica 43
CZ - Repubblica Ceca 39
TG - Togo 38
IQ - Iraq 35
BE - Belgio 33
BJ - Benin 33
PK - Pakistan 26
EC - Ecuador 21
LT - Lituania 21
UZ - Uzbekistan 18
AU - Australia 17
CO - Colombia 17
PY - Paraguay 15
VE - Venezuela 15
IL - Israele 14
IR - Iran 13
MA - Marocco 13
NP - Nepal 12
EG - Egitto 11
TN - Tunisia 11
CL - Cile 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
CH - Svizzera 9
JO - Giordania 9
KG - Kirghizistan 9
AL - Albania 8
KE - Kenya 8
SA - Arabia Saudita 8
BO - Bolivia 7
DK - Danimarca 7
HU - Ungheria 7
PE - Perù 7
GR - Grecia 6
LV - Lettonia 6
NO - Norvegia 6
SK - Slovacchia (Repubblica Slovacca) 6
BG - Bulgaria 5
HR - Croazia 5
KZ - Kazakistan 5
LB - Libano 5
GH - Ghana 4
JM - Giamaica 4
OM - Oman 4
PA - Panama 4
PH - Filippine 4
PT - Portogallo 4
RO - Romania 4
TH - Thailandia 4
UY - Uruguay 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GA - Gabon 3
GE - Georgia 3
GT - Guatemala 3
GY - Guiana 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
RS - Serbia 3
UG - Uganda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AF - Afghanistan, Repubblica islamica di 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
DZ - Algeria 2
EU - Europa 2
HN - Honduras 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MK - Macedonia 2
PS - Palestinian Territory 2
Totale 26.985
Città #
Dallas 2.256
Moscow 1.732
Singapore 1.283
Southend 1.107
Chandler 1.085
Ashburn 792
Hong Kong 698
Dublin 472
Beijing 383
Verona 344
New York 263
Woodbridge 239
Jacksonville 227
Munich 227
Los Angeles 226
Houston 194
The Dalles 174
Ann Arbor 169
Ho Chi Minh City 154
Lawrence 150
Princeton 150
Boardman 140
Wilmington 133
Helsinki 124
Jinan 115
Nanjing 94
Shenyang 90
São Paulo 90
Redondo Beach 87
Santa Clara 83
Buffalo 82
Hanoi 82
Tokyo 81
Sindelfingen 75
Seattle 74
London 65
Milan 65
Turku 63
Columbus 62
Redmond 61
Tianjin 58
Hebei 55
Council Bluffs 52
Hangzhou 50
Denver 49
Amsterdam 47
Montreal 47
Orem 47
Fairfield 43
Warsaw 43
Haikou 42
Ningbo 40
Nuremberg 40
Atlanta 39
Changsha 38
Lomé 38
Zhengzhou 38
Bologna 37
Stockholm 37
Brooklyn 36
Rome 35
San Francisco 35
Chennai 34
Chicago 34
Falkenstein 34
Frankfurt am Main 34
Phoenix 34
Redwood City 34
Seoul 34
Toronto 34
Cotonou 33
Guangzhou 33
Washington 33
Nanchang 32
Brussels 31
Brno 30
Johannesburg 29
Taizhou 29
Lappeenranta 28
Mexico City 28
Poplar 28
Taiyuan 28
Boston 25
Meda 25
Belo Horizonte 24
Falls Church 24
Jakarta 24
San Jose 24
Vienna 24
Rio de Janeiro 23
Jiaxing 22
Manchester 21
Da Nang 19
Norwalk 18
Brasília 17
Tashkent 17
Ankara 16
Charlotte 16
Curitiba 16
Kent 16
Totale 15.942
Nome #
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 576
Supplemental parenteral nutrition within an enhanced recovery program for open pancreatoduodenectomy for cancer: a pragmatic, multicenter, randomized controlled trial 374
Assessment of Psychological Burden in Individuals with Hereditary Risk of Pancreatic Cancer Under Surveillance: Evaluation of Distress 3 Years After Enrollment 303
Addressing Pancreatic Exocrine Insufficiency and the Impact of Pancreatic Enzyme Replacement Therapy Shortages in Europe 280
Diffusion of Robotic Platforms and New Devices in HPB Surgery: A European-African Hepato-Pancreato-Biliary Association (E-AHPBA) Survey 250
A rare case of three different tumors in the same pancreatic specimen: a case report and brief review of the literature 235
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 224
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 217
A Single Institution's 27-Year Surgical Experience with Pancreatic Neuroendocrine Tumors: Time Trends, Comparison of Current Staging Systems and Outcome Analysis 214
Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? 214
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 209
7T MRI and histology reveal early tissue and perfusion changes after radiofrequency ablation in a murine colorectal cancer model 208
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 205
Gα15 in early onset of pancreatic ductal adenocarcinoma 205
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma 204
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 202
Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases 201
Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study 190
A root-cause analysis of mortality following major pancreatectomy 189
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 189
Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay 189
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 187
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 186
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 182
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 180
Delaying surgery for patients with a previous SARS-CoV-2 infection 179
Preoperative surveillance rectal swab is associated with an increased risk of infectious complications in pancreaticoduodenectomy and directs antimicrobial prophylaxis: an antibiotic stewardship strategy? 174
Antibiotic Prophylaxis with Piperacillin-Tazobactam Reduces Post-Operative Infectious Complication after Pancreatic Surgery: An Interventional, Non-Randomized Study 173
Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis 173
Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review 172
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 169
Results of a surveillance protocol for pancreatic BD-IPMNs 168
Dual-tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT scan and G1-G2 non-functioning pancreatic neuroendocrine tumors: A single-center retrospective evaluation of 124 non-metastatic resected cases 168
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients 167
Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study 167
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 167
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 164
Cytoreduction after radiofrequency ablation of unresectable pancreatic adenocarcinoma: correlation between CA 19.9 serum levels and necrosis extent at CT 161
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 161
Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up 159
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 158
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer 158
Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation 157
Chyle leak after pancreatic surgery: validation of the International Study Group of Pancreatic Surgery classification 157
Ablation treatments in unresectable pancreatic cancer 156
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 156
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 155
Minimally invasive pancreatic surgery - a review 154
Use of an intraoperative wound protector to prevent surgical-site infection after pancreatoduodenectomy: randomized clinical trial 153
A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy 153
Can CT texture analysis predict resectability and surgical outcomes after neoadjuvant radiotherapy in pancreatic cancer patients? 151
Fhit down-regulation is an early event in pancreatic carcinogenesis 149
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 149
Percutaneous Radiofrequency Ablation of Unresectable Locally Advanced Pancreatic Cancer: Preliminary Results 147
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 147
Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma 147
Impact of preoperative biliary drainage on postoperative outcome after pancreaticoduodenectomy: An analysis of 1500 consecutive cases 146
Redefining the Role of Drain Amylase Value for a Risk-Based Drain Management after Pancreaticoduodenectomy: Early Drain Removal Still Is Beneficial 146
Variation of tumoral marker after radiofrequency ablation of pancreatic adenocarcinoma 145
Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer 145
The management of intraductal papillary mucinous neoplasms of the pancreas 145
Endoscopic placement of pancreatic stent for "Deep" pancreatic enucleations operative technique and preliminary experience at two high-volume centers 145
Dental plaque microbiota sequence counts for microbial profiling and resistance genes detection 144
Laser Treatment of Pancreatic Cancer with Immunostimulating Interstitial Laser Thermotherapy Protocol: Safety and Feasibility Results From Two Phase 2a Studies 144
Postoperative infections represent a major determinant of outcome after pancreaticoduodenectomy: Results from a high-volume center 143
Palliative therapy in pancreatic cancer-interventional treatment with radiofrequency ablation/irreversible electroporation 143
Endoscopic Ultrasound Features Associated with Malignancy and Aggressiveness of Nonhypovascular Solid Pancreatic Lesions: Results from a Prospective Observational Study 142
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases 141
Love (Pancreatic Surgery) in the Time of Cholera (COVID-19) 141
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 140
Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis 140
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 139
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma 139
Comparison between EUS-guided fine-needle aspiration cytology and EUS-guided fine-needle biopsy histology for the evaluation of pancreatic neuroendocrine tumors 139
Modified Frailty Index to Assess Risk in Elderly Patients Undergoing Distal Pancreatectomy: A Retrospective Single-Center Study 139
Long term outcome after minimally invasive and open Warshaw and Kimura techniques for spleen-preserving distal pancreatectomy: International multicenter retrospective study 137
ASO Visual Abstract: Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective Lymphadenectomy Protocol 137
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 136
Pancreaticojejunostomy With Externalized Stent vs Pancreaticogastrostomy With Externalized Stent for Patients With High-Risk Pancreatic Anastomosis: A Single-Center, Phase 3, Randomized Clinical Trial 136
Discovery of highly potent benzimidazole derivatives as indoleamine 2,3-dioxygenase-1 (IDO1) inhibitors: from structure-based virtual screening to in vivo pharmacodynamic activity 136
Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries 135
Pancreatoduodenectomy at the Verona Pancreas Institute: the Evolution of Indications, Surgical Techniques and Outcomes: A Retrospective Analysis of 3000 Consecutive Cases 134
Open radiofrequency ablation as upfront treatment for locally advanced pancreatic cancer: Requiem from a randomized controlled trial 133
Erratum: The borderline resectable/locally advanced pancreatic ductal adenocarcinoma staging with computed tomography/magnetic resonance imaging 132
401 consecutive minimally invasive distal pancreatectomies: lessons learned from 20 years of experience 132
Solid-pseudopapillary, Acinar, and Other Cystic Neoplasms 131
The emotional impact of surveillance programs for pancreatic cancer on high-risk individuals: A prospective analysis 130
Sex differences in oncogenic mutational processes 130
Robotic Dual-Console Distal Pancreatectomy: Could it be Considered a Safe Approach and Surgical Teaching even in Pancreatic Surgery? A Retrospective Observational Study Cohort 130
Computed tomography-based radiomic to predict resectability in locally advanced pancreatic cancer treated with chemotherapy and radiotherapy 129
Percutaneous ablation of pancreatic cancer 128
Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar 127
Surgery for Distal Cholangiocarcinoma 126
The borderline resectable/locally advanced pancreatic ductal adenocarcinoma staging with computed tomography/magnetic resonance imaging 126
ESGAR 2018 Book of Abstracts 126
Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma 126
Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence 125
Radiofrequency Ablation of Pancreatic Cancer 125
Role of local ablative techniques (Radiofrequency ablation and Irreversible Electroporation) in the treatment of pancreatic cancer 124
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 124
Totale 16.743
Categoria #
all - tutte 95.827
article - articoli 91.043
book - libri 0
conference - conferenze 1.705
curatela - curatele 0
other - altro 271
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.808
Totale 191.654


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021476 0 0 0 0 0 121 48 36 60 41 94 76
2021/20221.147 123 256 12 75 45 43 46 69 75 36 87 280
2022/20233.444 187 400 251 573 283 964 96 214 335 34 62 45
2023/20241.995 56 144 201 219 204 329 108 144 32 98 354 106
2024/20255.118 283 273 232 776 269 153 326 282 671 370 522 961
2025/202611.991 1.032 1.140 2.035 2.710 4.114 960 0 0 0 0 0 0
Totale 27.361